News

CBO finds health agency cuts would result in fewer new drugs
The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...
KFF Health News2d
NIH, FDA Cuts Would Lead To Fewer New Meds, CBO Analysis Indicates
An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...
Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...
Becker's Hospital Review2d
Cuts to NIH, FDA could slash drug approvals: 5 notes
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Thousands Laid off From NIH, FDA and CDC After Supreme Court Decision
On Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, ...
Congressional forecaster says Trump health research cuts would lead to fewer new drugs
President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on ...
Drug official’s retirement sparks worry at FDA
Curay, the acting director of the FDA’s Center for Drug Evaluation and Research, internally announced her retirement Monday.
FDA funding clash looms between Senate, House
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...